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Gold nanorods that have an absorption band in the near-infrared region and a photothermal effect have been
used as nanodevices for near-infrared imaging and thermal therapy. Choice of the optimal shape of gold nanorods
which relates optical properties and in vivo biodistribution is important for their applications. In the present study,
to investigate the relationship between the shape of gold nanorods and their biodistribution after intravenous
injection, we first prepared two types of gold nanorods that had distinct aspect ratios but had the same volume,
zeta potential, and PEG density on the gold surface. Biodistributions of the two types of gold nanorods after
intravenous injection into tumor-bearing mice were then compared. Although a slight difference in accumulation
in the spleen was observed, no significant difference was observed in the liver, lung, kidney, and tumors. These
results suggest that biodistribution of the gold nanorods in the aspect ratio range of 1.7 to 5.0, diameter of 10 to
50 nm, and volume of approximately 4 × 103 nm3 was dependent mainly on surface characteristics, PEG density,
and zeta potential.
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Gold nanorods are tiny, rod-shaped gold particles. They
have two distinctive different absorption bands derived
from the transverse and longitudinal surface plasmon
resonance of free electrons in the visible and near-
infrared (NIR) regions, respectively [1,2]. Gold nanorods
absorb NIR light, which is suitable for in vivo applica-
tions such as imaging and for photoradiation therapy be-
cause of maximal penetration of light into tissues [3].
Gold nanorods have a photothermal effect, i.e., the
adsorbed light energy is converted to heat [4]. Therefore,
gold nanorods are expected to be contrast agents for
NIR imaging and exothermic nanodevices for photother-
mal therapy.
Gold nanorods are prepared in the presence of the cat-
ionic detergent 1-hexadecyltrimethylammonium chloride
(cetyltrimethylammonium chloride; CTAB), which acts* Correspondence: niidome.takuro.655@m.kyushu-u.ac.jp
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in any medium, provided the original work is pas a stabilizer of gold nanorods. To apply gold nanorods
as medical nanodevices, biocompatible gold nanorods
have been prepared by coating with phosphatidylcholine
[5] or by modifying gold nanorods with polyethylene gly-
col (PEG) [6,7]. PEG-modified gold nanorods show high
dispersion stability, high circulation stability in the blood
after intravenous injection into mice [7], and accumula-
tion in tumors mediated by the enhanced permeability
and retention (EPR) effect [8,9]. The PEG-modified gold
nanorods have been applied to NIR imaging and photo-
dynamic/photothermal therapy of tumors [8,10-13].
The size and aspect ratio of gold nanorods are import-
ant factors of their uptake into cells [14-16] and biodis-
tribution [17-20]. Arnida et al. reported that rod-shaped
gold nanoparticles accumulated more efficiently in tumors
and less efficiently in the liver compared with sphere-
shaped gold nanoparticles [20]. However, the compared
gold nanorods and gold nanospheres had different volumes
and zeta potentials that affected cellular uptake (e.g.,
phagocytosis) [21]. Therefore, if we examine the effect of
the geometry of gold nanoparticles on biodistribution,
other parameters should be equivalent.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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nanorods that had distinct aspect ratios but had an identi-
cal volume, zeta potential, and surface structure. Biodistri-
butions of these nanorods after intravenous injection into
tumor-bearing mice were then compared.
Methods
Animals
Animal experiments were undertaken according to the
Guidelines for Animal Care and Use Committee, Kyushu
University (Fukuoka, Japan). Male ddY mice (Kyudo Co.,
Ltd., Saga, Japan) aged 5 to 6 weeks were used. Mice
were maintained in a temperature-controlled environ-
ment at 24°C with a 12-h light-dark cycle. They were
provided with drinking water and food ad libitum.
Preparation of gold nanorods of lower aspect ratio from
higher ones
Gold nanorods prepared by our research team were
obtained from Mitsubishi Materials Corp. (Tokyo, Japan)
and Dai Nippon Toryo Co. Ltd. (Tokyo, Japan) [22]. The
mean length and width of the as-obtained gold nanorods
were 49.6± 9.7 nm and 10.6 ± 3.2 nm, respectively (aspect
ratio, 5.0 ± 1.2). A suspension of gold nanorods containing
CTAB was stored at a constant temperature (37°C). Gold
nanorods were modified with PEG chains. Briefly, the gold
nanorods in the suspension were centrifuged at 14,000× g
for 10 min at room temperature, decanted, and re-
suspended in water to remove excess CTAB. Thiol-
terminated mPEG solution (molecular weight approxi-
mately 5,000 Da; NOF Corporation, Tokyo, Japan) was
added to the gold nanorod suspension at a PEG/gold
molar ratio of 1.0. The mixture of PEG solution and gold
nanorod suspension at a final gold concentration of 1 mM
was stirred for 24 h at room temperature. NIR pulsed laser
light (Nd:YAG 1064 nm, 750 mW, 20 Hz, approximately
6 mm in beam diameter) irradiated the mixture for 5 min.
The mean length and width of gold nanorods irradiated
with the NIR pulsed laser light were 27.0 ± 8.2 nm and
17.2± 3.7 nm, respectively (aspect ratio, 1.7 ± 0.9). A con-
trol mixture was not irradiated with the NIR pulsed laser
light. These mixtures were stirred for another 24 h at
room temperature and centrifuged twice at 14,000× g for
10 min at room temperature, decanted, and re-suspended
in water to remove remaining CTAB and excess PEG
reagent.
Characterization of PEG-modified gold nanorods
The absorption spectra of gold nanorods in the visible-to-
NIR light regions were measured with a V-670 spectropho-
tometer (Jasco, Tokyo, Japan). Gold nanorods and the PEG
layer on the gold nanorods were imaged with a transmis-
sion electron microscope (JEM-2010, JEOL, Tokyo, Japan)
after staining the PEG layer with 1% phosphotungstic acid[23]. Particle size distribution, surface area, and volume
were calculated from transmission electron microscopy
(TEM) images of 100 particles. Amounts of PEG modified
on the gold nanorods were evaluated by elemental analyses
according to our previous publication [24]. Zeta potentials
of gold nanorod suspensions in 0.2 M sodium phosphate
buffer (pH 7.4) were evaluated using a Malvern Zetasizer
Nano ZS (Malvern, Worcestershire, UK).
Biodistribution of gold nanorods
Tumor-bearing mice were used in biodistribution
experiments and were prepared as follows: Colon-26
cells: mouse colon carcinoma cells were cultured in
RPMI 1640 medium containing 10% fetal bovine serum,
100 U/mL penicillin, 100 μg/mL streptomycin, and
0.25 μg/mL amphotericin B. Cells were incubated at 37°C
under a 5% CO2-humidified atmosphere. Incubated
colon-26 cells were injected subcutaneously into the abdo-
men at 2× 106 cells in 100 μL of Hank's balanced salt so-
lution per mouse (ddY, male, 5 weeks, 29 to 35 g). They
were allowed to grow for 5 days, wherein the tumors
reached approximately 5 to 7 mm in diameter. PEG-
modified gold nanorods were injected into tumor-bearing
mice via the tail vein. Doses of PEG-modified gold nanor-
ods with an aspect ratio of 5.0 and PEG-modified gold
nanorods with an aspect ratio of 1.7 were at 1.01 and
1.05 mM of gold concentration in 10 μL/g body weight of
5% glucose solution, respectively. Mice were sacrificed
72 h after injection. Several hundred microliters of blood
were collected from the heart and immediately mixed with
1 mg ethylenediamine tetra-acetic acid. The liver, lung,
spleen, and kidney, as well as tumors, were collected.
These samples were added to approximately 4 mL aqua
regia and then heated overnight at 90°C to 100°C. Samples
were diluted in 0.5 M HCl to the appropriate volume.
Gold concentrations were quantified by inductively
coupled plasma mass spectrometry (ICP-MS) using an
Agilent 7500c system (Agilent. Tokyo, Japan). ICP-MS
measurement was done with thallium as the internal
standard.
Results and discussion
Preparation of PEG-modified gold nanorods with distinct
aspect ratios
To clarify the effect of the aspect ratio of gold nanorods
on biodistribution in mice, we prepared PEG-modified
gold nanorods with distinct aspect ratios. Gold nanorods
can be melted and reshaped by irradiation with NIR
pulsed laser light at the absorption wavelength of the
gold nanorods [24-26]. Based on those reports, the ori-
ginal gold nanorods with higher aspect ratio were trans-
formed to those of lower aspect ratio by irradiation with
laser light. After irradiation, maximum absorption and
the wavelength at the maximum absorption of the gold
Figure 2 TEM images of PEG-modified gold nanorods treated
without (A) and with (B) near-infrared pulsed laser light.
Samples were stained with 1% phosphotungstic acid; thereafter,
images were taken. Scale bars = 50 nm.
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wards a shorter wavelength (Figure 1). TEM images
revealed that the irradiated gold nanorods showed
mainly spherical or elliptical shapes and partly rod
shapes (Figure 2). For gold nanorods with and without
irradiation, PEG modified on the gold nanorods was
confirmed from a gray layer of PEG stained with phos-
photungstic acid. Particle sizes of gold nanorods in the
TEM images were measured; then, their distributions
were plotted (Figures 3A, B). Laser irradiation made the
size of the short axis of the gold nanorod increase and
the size of the long axis decrease. As a result, the size
distribution of the short and long axes overlapped. As-
pect ratios were calculated and then plotted (Figure 3C).
Half of the irradiated gold nanorods were transformed
to a spherical shape (aspect ratio, 1.0). The other irra-
diated gold nanorods were transformed to an elliptical
shape.
Several characteristics of the gold nanorods are summar-
ized in Table 1. The particle length of the short axis and
long axis increased from 10.6 to 17.2 nm and decreased
from 49.6 to 27.0 nm by laser irradiation, respectively.
Laser irradiation made the aspect ratio decrease from 5.0
to 1.7. The surface area and volume of the gold nanorods
were calculated on the assumption that a nanoparticle
with an aspect ratio of 1.0 was a sphere and a nanorod
with an aspect ratio >1.0 was a cylinder with a hemisphere
domain at both ends. The surface area decreased from
1.61× 103 nm2 to 1.42× 103 nm2 by laser irradiation. The
volume did not change significantly after irradiation. Previ-
ously, it was reported that irradiation of gold nanorods by
pulsed laser light caused fragmentation into smaller
particles [26] or fusion into larger particles [27,28].
However, in the irradiation condition described here,Figure 1 Absorption spectra of PEG-modified gold nanorods
treated without (A) and with (B) near-infrared pulsed laser
light.neither fragmentation nor fusion of the gold nanorods
was observed in TEM images. This was probably be-
cause the intensity of the pulsed laser light was not
sufficient to induce fragmentation of the gold nanor-
ods, and the PEG layer on the gold nanorods disturbed
the fusion between gold nanorods.
The amount of modified PEG on gold nanorods was
measured by elemental analyses (Table 1) [24]. The
number of modified PEG molecules on one particle
decreased from 9.50 × 102 to 8.25 × 102 by laser irradi-
ation. The actual release of PEG from the gold surface
to supernatant has been already confirmed at a similar
condition in our previous report [24]. However, the area
occupied by one PEG molecule as PEG density on the
gold nanorods and the zeta potentials of the gold nanor-
ods did not change after laser irradiation. These data
suggested that the laser irradiation of gold nanorods
resulted in transformation from a rod shape to a spher-
ical shape without changing the volume, PEG density, or
zeta potential.
Figure 3 Size distribution and aspect ratios of PEG-modified gold nanorods. Size distribution of PEG-modified gold nanorods treated
without (A) and with (B) near-infrared pulsed laser light. Closed and open bars show the size distributions of the short and long axes of gold
nanorods, respectively. (C) Aspect ratios of PEG-modified gold nanorods without (closed bars) and with (open bars) pulsed laser light.
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We compared the biodistribution of PEG-modified gold
nanorods with distinct aspect ratios but with the same
volume, PEG density, and zeta potentials. Prepared gold
nanorods with aspect ratios of 5.0 and 1.7 were injected
intravenously into tumor-bearing mice to which colon-
26 cells were subcutaneously injected. Mice were sacri-
ficed 72 h after the injection, and the collected organs
were dissolved using aqua regia. At this time point, it
has been already shown that little amount of PEG-
modified gold nanorods was observed in the blood and
that most gold nanorods were distributed to organs
[7,9]. Gold concentrations in the samples were measured
by ICP-MS. Both types of injected gold nanorods accu-
mulated mainly in the liver and spleen (Figure 4A). MostTable 1 Characteristics of PEG-modified gold nanorods treate
Particle size of short axis (nm)
Particle size of long axis (nm)
Aspect ratio
Surface area (×10−3 nm2)
Volume (×10−3 nm3)
Number of modified PEG on one particle (×10−2)
Area occupied by one PEG molecule (nm2)
Zeta potential (mV)
Data are the mean ± standard deviation. aNo significant difference from the value ogold nanorods with aspect ratios of 5.0 and 1.7 were
probably cleared by the reticuloendothelial system (RES)
in the liver and spleen [28].
Figure 4B shows the concentration of accumulated
gold nanorods in the organs as percentage of injected
dose per gram of tissue or milliliter of blood. The con-
centration is an important parameter for photothermal
therapy and bioimaging mediated by gold nanorods. Ac-
cumulation of gold nanorods with an aspect ratio of 1.7
in the spleen was slightly lower than that of gold nanor-
ods with an aspect ratio of 5.0, although statistical sig-
nificance was low (0.1 > p > 0.05; Figure 4B). In the case
of the liver, lung, and kidney, no difference between the
gold nanorods with aspect ratios of 1.7 and 5.0 was
observed. No difference was observed in the tumors,d without and with near-infrared pulsed laser light
Without irradiation With irradiation
10.6 ± 3.2 17.2 ± 3.7
49.6 ± 9.7 27.0 ± 8.2
5.0 ± 1.2 1.7 ± 0.9
1.61 ± 0.43 1.42 ± 0.40
4.02 ± 1.81 4.32 ± 1.70a
9.50 ± 4.28 8.25 ± 3.25
1.82 ± 0.29 1.82 ± 0.33a
0.48 ± 1.66 1.83 ± 3.34a
f gold nanorods without laser irradiation.
Figure 4 Biodistribution of PEG-modified gold nanorods in
tumor-bearing mice. The biodistribution of PEG-modified gold
nanorods at 72 h after intravenous injection was compared. Closed
bars and open bars indicate the biodistribution of PEG-modified
gold nanorods at aspect ratios of 5.0 (n= 5) and 1.7 (n= 4),
respectively. (A) The percentage of injected dose per organ and (B)
percentage of injected dose per gram of tissue or milliliter of blood,
respectively. Bars are the standard error from the mean.
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ods was not sufficient to influence the EPR effect in the
tumors. The slight difference observed in the spleen may
have been due to physical filtration in this organ as
observed for larger particles (>200 nm) [29,30]. It may
not have been due to changes in the contribution of the
RES in the spleen because a significant difference in the
accumulation in the liver (where many Kupffer cells
(macrophage-like cells) constitute the RES at sinusoids)
was not observed. These results suggested that the shape
of the gold nanorods barely affected the biodistribution of
gold nanorods after intravenous injection into tumor-
bearing mice except for that in the spleen (though the
change in biodistribution was slight). Previously, we com-
pared biodistributions of several types of gold nanorods,which have different zeta-potentials and PEG densities on
the gold surface but have the same aspect ratio [8,9]. In
those studies, the surface structure of the gold nanorods
strongly affected their biodistributions after intravenous
injection. Therefore, it can be concluded that the biodistri-
bution would be more affected primarily by the surface
characteristics of the gold nanorods than the aspect ratio.
Conclusions
In the present study, the shape of the original gold
nanorods was changed by irradiation with NIR light to a
spherical form. Then, we obtained two types of PEG-
modified gold nanorods with distinct aspect ratios but
with the same volume, PEG density, and zeta potential.
The change in the aspect ratio of the gold nanorods did
not affect the biodistribution appreciably. These results
suggest that the biodistribution of gold nanorods in the
aspect ratio range of 1.7 to 5.0 and size of 10 to 50 nm
at a volume of approximately 4 × 103 nm3 is dependent
mainly on the surface characteristics, PEG density, and
zeta potential. If the application of gold nanorods to
therapeutic use is considered, the gold nanorods circu-
lating in the blood or other tissues such as tumors are
irradiated with NIR light. Irradiation with the pulsed
laser light will induce the shape change of the gold
nanorods and release of molecules bound on the gold
nanorods without changing their biodistribution. On the
other hand, irradiation with continuous wave laser light can
heat the gold nanorods continuously without changing the
shape of the gold nanorods [24]. Thus, combinations of
gold nanorods and different modes of light irradiation pro-
vide us various drug delivery/release and heating systems,
and it will be an advantage of gold nanorods over other
types of nanoparticles. The results obtained in this study
will be used as basic information on the in vivo application
not only of gold nanorods with various aspect ratios, but
also of other types of anisotropic nanoparticles.
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